CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
CN Stock MarketDetailed Quotes
300016 Beijing Beilu Pharmaceutical
- 6.55
- +0.18+2.83%
Market Closed Apr 30 15:00 CST
3.22BMarket Cap192.65P/E (TTM)
6.63High6.37Low99.42KlotVolume6.37Open6.37Pre Close64.91MTurnover2.02%Turnover Ratio233.93P/E (Static)491.95MShares8.9752wk High2.05P/B3.22BFloat Cap4.1752wk Low7.64Limit Up491.18MShs Float43.97Historical High5.10Limit Down4.08%Amplitude1.91Historical Low--Dividend TTM6.53Avg Price43.46KlotAsk--Div YieldTTM100Lot Size54.97KlotBid
Beijing Beilu Pharmaceutical Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 36.23%282.68M | 10.42%983.55M | 12.30%729.72M | 8.20%473.93M | 10.35%207.51M | 16.30%890.72M | 16.60%649.82M | 24.70%438.03M | 2.23%188.04M | -10.93%765.88M |
| Operating revenue | 36.23%282.68M | 10.42%983.55M | 12.30%729.72M | 8.20%473.93M | 10.35%207.51M | 16.30%890.72M | 16.60%649.82M | 24.70%438.03M | 2.23%188.04M | -10.93%765.88M |
| Other operating revenue | ---- | 56.86%10.07M | ---- | 313.48%3.57M | ---- | 44.96%6.42M | ---- | -58.00%864.44K | ---- | 44.69%4.43M |
| Total operating cost | 41.38%270.75M | 3.51%980.95M | 4.51%705.51M | 1.74%452.06M | 5.58%191.5M | 19.91%947.67M | 24.16%675.05M | 33.75%444.33M | 21.20%181.38M | 2.25%790.34M |
| Operating cost | 67.41%154.19M | 9.04%514.66M | 9.86%364.6M | 5.67%233.59M | -6.45%92.11M | 38.15%472.01M | 44.72%331.88M | 55.04%221.05M | 34.66%98.45M | 5.31%341.66M |
| Operating tax surcharges | 35.47%3.65M | 25.69%12.93M | 8.63%9.24M | 8.74%6.17M | 49.61%2.69M | -10.15%10.29M | 10.22%8.51M | 7.29%5.68M | -25.30%1.8M | 11.04%11.45M |
| Operating expense | 8.88%56.67M | 12.12%243.35M | 14.98%177.55M | 10.50%112.93M | 52.54%52.05M | 3.08%217.05M | 4.44%154.42M | 16.57%102.2M | -12.18%34.12M | -26.03%210.56M |
| Administration expense | 16.48%21.02M | 8.72%88.86M | 9.95%61.03M | 6.66%39.15M | 1.25%18.05M | -4.61%81.74M | -15.07%55.51M | -5.26%36.71M | -6.55%17.82M | 8.54%85.69M |
| Financial expense | 8.61%13.81M | 17.29%51.91M | 3.99%39.91M | -0.93%24.77M | 4.78%12.72M | 5.43%44.26M | 32.98%38.38M | 38.91%25M | 38.93%12.14M | 53.22%41.98M |
| -Interest expense (Financial expense) | 9.99%15.14M | 9.16%58.01M | 11.00%44.03M | 10.94%28.16M | 10.00%13.76M | 11.53%53.14M | 12.81%39.66M | 11.11%25.38M | 13.07%12.51M | 7.82%47.64M |
| -Interest Income (Financial expense) | -6.13%-1.79M | 54.52%-5.38M | 32.92%-4.48M | 21.61%-3.39M | 35.24%-1.68M | -39.34%-11.82M | -11.01%-6.68M | -7.43%-4.32M | -37.90%-2.6M | 35.71%-8.48M |
| Research and development | 54.07%21.4M | -43.40%69.24M | -38.42%53.17M | -33.98%35.45M | -18.50%13.89M | 23.55%122.33M | 33.70%86.35M | 34.51%53.7M | 128.07%17.04M | 109.64%99.01M |
| Credit Impairment Loss | 9.53%963.46K | 117.33%664.25K | 213.47%1.99M | 133.17%566.92K | 143.39%879.63K | -598.64%-3.83M | -226.30%-1.76M | -202.20%-1.71M | -64.45%361.41K | -42.19%768.89K |
| Asset Impairment Loss | 2.53%-813.01K | 78.02%-9.93M | -0.86%-3.78M | 6.10%-3.22M | -34.34%-834.08K | -89.72%-45.18M | -25.60%-3.75M | -215.35%-3.43M | 66.55%-620.86K | -572.32%-23.81M |
| Other net revenue | 2,781.53%3.73M | 92.64%-3.2M | -108.44%-1.31M | -115.10%-1.27M | -103.84%-139.04K | -489.15%-43.49M | -45.72%15.49M | -55.68%8.41M | -36.81%3.62M | -72.23%11.18M |
| Fair value change income | 102.42%89K | 14.39%-11.95M | -246.37%-13.45M | -236.13%-8.91M | -229.90%-3.68M | -153.19%-13.96M | -56.54%9.19M | -49.60%6.54M | -43.54%2.84M | 88.78%26.24M |
| Invest income | 128.30%1.94M | 22.80%7.36M | 27.39%5.75M | 4.16%3.78M | 530.08%849.8K | 205.20%5.99M | 264.67%4.51M | 192.70%3.63M | -150.05%-197.59K | -143.39%-5.7M |
| -Including: Investment income associates | -73.68%-644.59K | -138.92%-760.77K | -108.82%-149.73K | -70.70%330.16K | 53.16%-371.13K | 117.23%1.95M | 185.91%1.7M | 152.80%1.13M | -10,627.56%-792.28K | -585.00%-11.35M |
| Asset deal income | -69,909.93%-1.27M | -86.25%122.94K | -99.79%1.82K | -99.79%1.82K | --1.82K | 801.04%894.31K | 772.62%866.11K | --866.11K | ---- | -21.32%99.25K |
| Other revenue | 6.45%2.82M | -16.39%10.53M | 27.39%8.19M | 158.83%6.51M | 112.50%2.65M | -7.27%12.59M | -44.70%6.43M | -73.03%2.52M | 7.54%1.25M | -11.30%13.58M |
| Operating profit | -1.27%15.66M | 99.41%-595.83K | 335.24%22.9M | 874.88%20.6M | 54.28%15.86M | -656.17%-100.44M | -123.10%-9.74M | -94.44%2.11M | -74.30%10.28M | -110.44%-13.28M |
| Add:Non operating Income | 208.58%152.19K | -7.35%1.64M | -62.67%566.85K | -93.32%100.53K | 92.12%49.32K | 386.71%1.77M | 3,896.51%1.52M | 3,858.83%1.5M | 25,570.58%25.67K | 31.74%363.23K |
| Less:Non operating expense | 4,948.19%187.52K | -26.48%1.83M | 71.99%1.4M | -51.01%266.21K | -88.33%3.71K | 34.81%2.48M | -41.90%811.19K | -29.80%543.44K | -94.07%31.83K | -63.84%1.84M |
| Total profit | -1.77%15.63M | 99.23%-783.88K | 344.49%22.08M | 564.83%20.44M | 54.82%15.91M | -585.25%-101.15M | -122.14%-9.03M | -91.76%3.07M | -73.97%10.28M | -112.06%-14.76M |
| Less:Income tax cost | -45.79%2.32M | 94.14%-1.05M | 163.79%3.07M | 378.17%5.24M | 4,586.93%4.29M | -75.80%-17.95M | -253.02%-4.81M | -164.74%-1.88M | -98.05%91.47K | -184.67%-10.21M |
| Net profit | 14.47%13.3M | 100.32%267.65K | 550.92%19M | 206.69%15.2M | 14.11%11.62M | -1,728.99%-83.2M | -110.00%-4.21M | -85.59%4.96M | -70.72%10.18M | -104.12%-4.55M |
| Net profit from continuing operation | 14.47%13.3M | 100.32%267.65K | 550.92%19M | 206.69%15.2M | 14.11%11.62M | -1,728.99%-83.2M | -110.00%-4.21M | -85.59%4.96M | -70.72%10.18M | -104.12%-4.55M |
| Less:Minority Profit | -1,400.24%-1.24M | -16.96%-13.38M | 12.43%-5.39M | 6.54%-4.34M | 103.97%95.08K | 27.72%-11.44M | 52.87%-6.16M | 17.80%-4.65M | 46.69%-2.39M | -4.02%-15.83M |
| Net profit of parent company owners | 26.13%14.54M | 119.02%13.65M | 1,156.34%24.39M | 103.52%19.54M | -8.35%11.53M | -735.92%-71.76M | -96.48%1.94M | -76.02%9.6M | -67.97%12.58M | -91.01%11.28M |
| Earning per share | ||||||||||
| Basic earning per share | 25.96%0.0296 | 120.00%0.03 | 1,142.50%0.0497 | 100.00%0.04 | -8.20%0.0235 | -850.00%-0.15 | -96.44%0.004 | -75.00%0.02 | -68.00%0.0256 | -92.31%0.02 |
| Diluted earning per share | 16.14%0.0482 | 228.57%0.09 | 86.73%0.0999 | 40.00%0.07 | -0.95%0.0415 | -187.50%-0.07 | -64.17%0.0535 | -54.55%0.05 | -49.58%0.0419 | -71.43%0.08 |
| Other composite income | ||||||||||
| Total composite income | 14.47%13.3M | 100.32%267.65K | 550.92%19M | 206.69%15.2M | 14.11%11.62M | -1,728.99%-83.2M | -110.00%-4.21M | -85.59%4.96M | -70.72%10.18M | -104.15%-4.55M |
| Total composite income of parent company owners | 26.13%14.54M | 119.02%13.65M | 1,156.34%24.39M | 103.52%19.54M | -8.35%11.53M | -735.92%-71.76M | -96.48%1.94M | -76.02%9.6M | -67.97%12.58M | -90.96%11.28M |
| Total composite income of minority owners | -1,400.24%-1.24M | -16.96%-13.38M | 12.43%-5.39M | 6.54%-4.34M | 103.97%95.08K | 27.72%-11.44M | 52.87%-6.16M | 17.80%-4.65M | 46.69%-2.39M | -4.02%-15.83M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.